Plerixafor Patent Expiration
Plerixafor is Used for mobilizing hematopoietic stem cells in patients with non-Hodgkin's lymphoma and multiple myeloma for autologous transplantation. It was first introduced by Genzyme Corp
Plerixafor Patents
Given below is the list of patents protecting Plerixafor, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Mozobil | US6987102 | Methods to mobilize progenitor/stem cells |
Jul 22, 2023
(Expired) | Genzyme |
| Mozobil | US7897590 | Methods to mobilize progenitor/stem cells |
Jul 22, 2023
(Expired) | Genzyme |
| Mozobil | USRE42152 | Aromatic-linked polyamine macrocyclic compounds with anti-HIV activity |
Dec 10, 2018
(Expired) | Genzyme |
Plerixafor's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List